Data as of Nov 26
| +4.41 / +4.50%|
The 5 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 93.00, with a high estimate of 124.00 and a low estimate of 60.00. The median estimate represents a -9.22% decrease from the last price of 102.44.
The current consensus among 6 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.